Exploring the realm of cardiac gene expression unveils the intricate orchestration of molecular processes shaping the heart's structure and function. This field delves into the activation and suppression of genes, orchestrating the synthesis of proteins crucial for cardiac well-being. By scrutinizing the nuances of cardiac gene expression, scientists strive to decode the genetic intricacies underlying cardiovascular diseases, pinpointing potential therapeutic avenues. The intricate dance of genes within the heart intricately influences fundamental processes like cellular growth, signaling cascades, and contractility. As research in cardiac gene expression progresses, it holds the potential to revolutionize our understanding of cardiac development, pathology, and personalized treatment approaches, ushering in a new era of improved cardiovascular health and patient outcomes.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States